FABP5, fatty acid binding protein 5, 2171

N. diseases: 85; N. variants: 1
Disease: Agnosia for Pain ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0563625
Disease: Agnosia for Pain
Agnosia for Pain 		0.020 Biomarker disease BEFREE α-Truxillic acid monoesters (TAMEs) constitute a class of inhibitors targeting fatty acid binding protein 5 (FABP5), whose inhibition produces analgesia in animal models. 31237895 2019
CUI: C0563625
Disease: Agnosia for Pain
Agnosia for Pain 		0.020 Biomarker disease BEFREE Previous work indicates that systemically administered FABP5 inhibitors produce analgesia in models of inflammatory pain. 28326944 2017